Reducing acetylated tau is neuroprotective in brain injury
Open accessAbstract
Traumatic brain injury (TBI) is the largest non-genetic, non-aging related risk factor for Alzheimer's disease (AD). We report here that TBI induces tau acetylation (ac-tau) at sites acetylated also in human AD brain. This is mediated by S-nitrosylated-GAPDH, which simultaneously inactivates Sirtuin1 deacetylase and activates p300/CBP acetyltransferase, increasing neuronal ac-tau. Subsequent tau mislocalization causes neurodegeneration and neurobehavioral impairment, and ac-tau accumulates in the blood. Blocking GAPDH S-nitrosylation, inhibiting p300/CBP, or stimulating Sirtuin1 all protect mice from neurodegeneration, neurobehavioral impairment, and blood and brain accumulation of ac-tau after TBI. Ac-tau is thus a therapeutic target and potential blood biomarker of TBI that may represent pathologic convergence between TBI and AD. Increased ac-tau in human AD brain is further augmented in AD patients with history of TBI, and patients receiving the p300/CBP inhibitors salsalate or diflunisal exhibit decreased incidence of AD and clinically diagnosed TBI.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Tau ablation improves outcomes in models of TBI and high-salt diet-induced vascular dysfunction, with improvements in cognitive performance.
“Beyond neurodegenerative and neurodevelopmental disorders, tau ablation has also been shown to improve outcomes in models of neurological injury and vascular stress, such TBI and high-salt diet-induced vascular dysfunction, with associated improvements in cognitive performance [72, 86, 87].”
From Tau Ablation Rewires Brain Cell Programs in Health and Restores Function in Disease (2026) · cites this paper as [72]
The Results section on p300/CBP inhibition reports that reducing acetylated tau after TBI protected mice from learning and memory deficits. It says this treatment did not change total tau, so it does not establish an effect of tau ablation. No passage found on high-salt diet-induced vascular dysfunction (searched: high-salt diet, vascular dysfunction, tau ablation); the indexed passages have no page numbers. (LLM, conf=0.86)
Experimental — accuracy not yet measuredAcetylation of tau is an early pathological feature of neurodegeneration; acetylated tau inhibits its degradation, promotes pathological aggregation and propagation, and contributes to tauopathy.
“In addition, the acetylation of tau is an early pathological feature of neurodegeneration. Acetylated tau inhibits its degradation, promotes pathological aggregation and propagation, and contributes to tauopathy [46–51].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [51]
Inhibiting p300 with salsalate induces tau deacetylation, preserves tau axonal localization, and protects mice from neurodegeneration.
“Inhibiting p300 with salsalate, a non-steroidal anti-inflammatory drug, could induce tau deacetylation, preserve tau axonal localization, and protect mice from neurodegeneration [51].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [51]
Abnormal acetylation of tau on lysine residues spans the microtubule-binding repeat region (MTBR), and this modification alone is sufficient to induce tau pathology and neurodegeneration.
“Abnormal acetylation of tau on lysine residues spans the microtubule-binding repeat region (MTBR), and this modification alone is sufficient to induce tau pathology and neurodegeneration [51].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Analyzing real-time PCR data by the comparative CT method
Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190 · see citing works
Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092 · see citing works
Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,992 · see citing works
Quantification of histochemical staining by color deconvolution.
Ruifrok, A. C. C., & Johnston, D. A. (2001) · PubMed · Cited by 2,029 · see citing works
Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
Min, S.-W., Cho, S.-H., Zhou, Y., Schroeder, S., Haroutunian, V., Seeley, W. W., Huang, E. J., Shen, Y., Masliah, E., Mukherjee, C., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.044 · Cited by 949 · see citing works
Self-citationS-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration
Uehara, T., Nakamura, T., Yao, D., Shi, Z., Gu, Z., Ma, Y., Masliah, E., Nomura, Y., & Lipton, S. A. (2006) · Nature · doi:10.1038/nature04782 · Cited by 908 · see citing works
Ma, V. Y., Chan, L. E., & Carruthers, K. J. (2014) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2013.10.032 · Cited by 839 · see citing works
The acetylation of tau inhibits its function and promotes pathological tau aggregation
Cohen, T. J., Guo, J. L., Hurtado, D. E., Kwong, L. K., Mills, I. P., Trojanowski, J. Q., & Lee, V. M. Y. (2011) · Nature Communications · doi:10.1038/ncomms1255 · Cited by 724 · see citing works
Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease
Wesseling, H., Mair, W., Kumar, M., Schlaffner, C. N., Tang, S., Beerepoot, P., Fatou, B., Guise, A. J., Cheng, L., Takeda, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.029 · Cited by 688 · see citing works
Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?
Johnson, V. E., Stewart, W., & Smith, D. H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2808 · Cited by 587 · see citing works
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects
Isgrò, M. A., Bottoni, P., & Scatena, R. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-7215-0_9 · Cited by 577 · see citing works
Network-based approach to prediction and population-based validation of in silico drug repurposing
Cheng, F., Desai, R. J., Handy, D. E., Wang, R., Schneeweiss, S., Barabási, A.-L., & Loscalzo, J. (2018) · Nature Communications · doi:10.1038/s41467-018-05116-5 · Cited by 552 · cited 2× · see citing works
“Two cohort analyses were conducted to evaluate the predicted association, based on individual level of longitudinal patient data and pharmacoepidemiologic methods, as previously established (Cheng et al., 2018).”
BackgroundMethodSelf-citationGAPDH mediates nitrosylation of nuclear proteins
Kornberg, M. D., Sen, N., Hara, M. R., Juluri, K. R., Nguyen, J. V., Snowman, A. M., Law, L., Hester, L. D., & Snyder, S. H. (2010) · Nature Cell Biology · doi:10.1038/ncb2114 · Cited by 394 · see citing works
Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture
Forrester, M. T., Thompson, J. W., Foster, M. W., Nogueira, L., Moseley, M. A., & Stamler, J. S. (2009) · Nature Biotechnology · doi:10.1038/nbt.1545 · Cited by 387 · see citing works
Self-citationPhosphorylation of different tau sites during progression of Alzheimer’s disease
Neddens, J., Temmel, M., Flunkert, S., Kerschbaumer, B., Hoeller, C., Loeffler, T., Niederkofler, V., Daum, G., Attems, J., & Hutter-Paier, B. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0557-6 · Cited by 384 · see citing works
Discovery of a Proneurogenic, Neuroprotective Chemical
Pieper, A. A., Xie, S., Capota, E., Estill, S. J., Zhong, J., Long, J. M., Becker, G. L., Huntington, P. J., Goldman, S. E., Shen, C.-H., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.018 · Cited by 350 · see citing works
Self-citationFluid biomarkers for mild traumatic brain injury and related conditions
Zetterberg, H., & Blennow, K. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.127 · Cited by 328 · see citing works
Cook, C. N., Carlomagno, Y., Gendron, T. F., Dunmore, J. H., Scheffel, K., Stetler, C. T., Davis, M., Dickson, D. W., Jarpe, M. B., Deture, M. A., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt402 · Cited by 309 · see citing works
Cao, G., Xing, J., Xiao, X., Liou, A. K. F., Gao, Y., Yin, X., Clark, R. S. B., Graham, S. H., & Chen, J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2826-07.2007 · Cited by 304 · see citing works
Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies
Irwin, D. J., Cohen, T. J., Grossman, M., Arnold, S. E., Xie, S. X., Lee, V. M.-Y., & Trojanowski, J. Q. (2012) · Brain · doi:10.1093/brain/aws013 · Cited by 281 · see citing works
Tracy, T. E., Sohn, P. D., Minami, S. S., Wang, C., Min, S.-W., Li, Y., Zhou, Y., Le, D., Lo, I., Ponnusamy, R., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.005 · Cited by 277 · see citing works
Self-citationP7C3 Neuroprotective Chemicals Function by Activating the Rate-Limiting Enzyme in NAD Salvage
Wang, G., Han, T., Nijhawan, D., Theodoropoulos, P., Naidoo, J., Yadavalli, S., Mirzaei, H., Pieper, A. A., Ready, J. M., & McKnight, S. L. (2014) · Cell · doi:10.1016/j.cell.2014.07.040 · Cited by 243 · see citing works
Self-citationLi, Y., Li, Y., Li, X., Zhang, S., Zhao, J., Zhu, X., & Tian, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169650 · Cited by 243 · see citing works
Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI
Shahim, P., Politis, A., van der Merwe, A., Moore, B., Ekanayake, V., Lippa, S. M., Chou, Y., Pham, D. L., Butman, J. A., Diaz-Arrastia, R. R., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009985 · Cited by 236 · see citing works
Absence of CX3CR1 impairs the internalization of Tau by microglia
Bolós, M., Llorens-Martín, M., Perea, J. R., Jurado-Arjona, J., Rábano, A., Hernández, F., & Avila, J. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0200-1 · Cited by 231 · see citing works
Disruption of the Axon Initial Segment Cytoskeleton Is a New Mechanism for Neuronal Injury
Schafer, D. P., Jha, S., Liu, F., Akella, T., McCullough, L. D., & Rasband, M. N. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3376-09.2009 · Cited by 222 · see citing works
Self-citationHughes, R. O., Bosanac, T., Mao, X. R., Engber, T. M., DiAntonio, A., Milbrandt, J., Devraj, R. V., & Krauss, R. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108588 · Cited by 186 · see citing works
Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline
Ryan, J. L., Storey, E., Murray, A. M., Woods, R. L., Wolfe, R. S., Reid, C. M., Nelson, M. R., Chong, T. T. ‐., Williamson, J. D., Ward, S. A., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009277 · Cited by 184 · see citing works
Nitric Oxide–GAPDH–Siah: A Novel Cell Death Cascade
Hara, M. R., & Snyder, S. H. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9011-6 · Cited by 173 · see citing works
Mondello, S., Sorinola, A., Czeiter, E., Vámos, Z., Amrein, K., Synnot, A., Donoghue, E., Sándor, J., Wang, K., Diaz-Arrastia, R. R., et al. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2017.5182 · Cited by 168 · see citing works
Sohn, P. D., Tracy, T. E., Son, H.-I., Zhou, Y., Leite, R. E. P., Miller, B. L., Seeley, W. W., Grinberg, L. T., & Gan, L. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0109-0 · Cited by 160 · see citing works
Self-citationEVANS, D. B., Rank, K. B., Bhattacharya, K., Thomsen, D. R., Gurney, M. E., & Sharma, S. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000808200 · Cited by 155 · see citing works
Specific tau variants in the brains of patients with myotonic dystrophy
Vermersch, P., Sergeant, N., Ruchoux, M., Hofmann-Radvanyi, H., Wattez, A., Petit, H., Dewailly, P., & Delacourte, A. (1996) · Neurology · doi:10.1212/wnl.47.3.711 · Cited by 146 · see citing works
Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease
Kraus, A., Saijo, E., Metrick, M. A., Newell, K., Sigurdson, C. J., Zanusso, G., Ghetti, B., & Caughey, B. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1947-3 · Cited by 143 · see citing works
Self-citationYin, T. C., Britt, J. K., Jesús‐Cortés, H. D., Lü, Y., Genova, R. M., Khan, M. Z., Voorhees, J. R., Shao, J., Katzman, A. C., Huntington, P. J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.030 · Cited by 123 · see citing works
Self-citationHuman Serum Metabolites Associate With Severity and Patient Outcomes in Traumatic Brain Injury
Orešič, M., Posti, J. P., Kamstrup‐Nielsen, M. H., Takala, R. S. K., Lingsma, H. F., Mattila, I. M., Jäntti, S. E., Katila, A. J., Carpenter, K. L. H., Ala-Seppälä, H. M., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.07.015 · Cited by 116 · see citing works
Extracellular Monomeric Tau Is Internalized by Astrocytes
Perea, J. R., López, E., Díez-Ballesteros, J. C., Ávila, J., Hernández, F., & Bolós, M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00442 · Cited by 114 · see citing works
Biomarker-based dissection of neurodegenerative diseases
Olsson, B., Zetterberg, H., Hampel, H. J., & Blennow, K. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.04.006 · Cited by 96 · see citing works
Dutca, L. M., Stasheff, S. F., Hedberg‐Buenz, A., Rudd, D. S., Batra, N., Blodi, F. R., Yorek, M. S., Yin, T. C., Shankar, M., Herlein, J. A., et al. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15468 · Cited by 92 · see citing works
Self-citationPosti, J. P., Hossain, I., Takala, R. S. K., Liedes, H., Newcombe, V., Outtrim, J. G., Katila, A. J., Frantzén, J., Ala-Seppälä, H. M., Coles, J., et al. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2016.4442 · Cited by 92 · see citing works
Vázquez‐Rosa, E., Shin, M., Dhar, M., Chaubey, K., Cintrón-Pérez, C. J., Tang, X., Liao, X., Miller, E., Koh, Y., Barker, S., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010430117 · Cited by 88 · see citing works
Self-citationShekhar, S., Kumar, R. K., Rai, N., Kumar, V. L., Singh, K. K., Upadhyay, A. D., Tripathi, M., Dwivedi, S. N., Dey, A. B., & Dey, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159099 · Cited by 80 · see citing works
In vivo detection of cerebral tau pathology in long-term survivors of traumatic brain injury
Gorgoraptis, N., Li, L. M., Whittington, A., Zimmerman, K. A., Maclean, L. M., McLeod, C., Ross, E., Heslegrave, A., Zetterberg, H., Passchier, J., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1993 · Cited by 74 · see citing works
Self-citationArun, P., Abu-Taleb, R., Oguntayo, S., Tanaka, M., Wang, Y., Valiyaveettil, M., Long, J., Zhang, Y., & Nambiar, M. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.07.047 · Cited by 73 · see citing works
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity
Shirakawa, K., Wang, L., Man, N., Maksimoska, J., Sorum, A. W., Lim, H. W., Lee, I. S., Shimazu, T., Newman, J. C., Schröder, S., et al. (2016) · eLife · doi:10.7554/elife.11156 · Cited by 72 · see citing works
Isolation of Mitochondria from the CNS
Kristián, T. (2010) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0722s52 · Cited by 69 · see citing works
Yin, T. C., Voorhees, J. R., Genova, R. M., Davis, K., Madison, A. M., Britt, J. K., Cintrón-Pérez, C. J., McDaniel, L., Harper, M. M., & Pieper, A. A. (2016) · eNeuro · doi:10.1523/eneuro.0220-16.2016 · Cited by 69 · see citing works
Self-citationVázquez‐Rosa, E., Watson, M. R., Sahn, J. J., Hodges, T. R., Schroeder, R. E., Cintrón-Pérez, C. J., Shin, M., Yin, T. C., Emery, J. L., Martin, S. F., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00543 · Cited by 65 · see citing works
Self-citationNakamura, T., & Lipton, S. A. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7916 · Cited by 65 · see citing works
CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease
Waldmeier, P. C., Spooren, W. P. J. M., & Hengerer, B. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000300 · Cited by 55 · see citing works
Individualized correction of neuron-specific enolase (NSE) measurement in hemolyzed serum samples
Tolan, N. V., Vidal‐Folch, N., Algeciras‐Schimnich, A., Singh, R. J., & Grebe, S. K. G. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.06.009 · Cited by 54 · see citing works
Lococo, P. M., Risinger, A. L., Smith, H. R., Chavera, T. S., Berg, K. A., & Clarke, W. P. (2017) · eLife · doi:10.7554/elife.29626 · Cited by 53 · see citing works
Lucke-Wold, B., Seidel, K., Udo, R., Omalu, B., Ornstein, M., Nolan, R. L., Rosen, C., & Ross, J. (2017) · Journal of Neurology and Neurosurgery · doi:10.19104/jnn.2017.40 · Cited by 49 · see citing works
Nitrosylation of GAPDH augments pathological tau acetylation upon exposure to amyloid-β
Sen, T., Saha, P., & Sen, N. (2018) · Science Signaling · doi:10.1126/scisignal.aao6765 · Cited by 47 · see citing works
Tau is reduced in AD plasma and validation of employed ELISA methods.
Sparks, D. L., Kryscio, R. J., Sabbagh, M. N., Ziolkowski, C. H. J., Lin, Y., Sparks, L. M., Liebsack, C., & Johnson‐Traver, S. (2012) · Europe PMC (PubMed Central) · Cited by 45 · see citing works
Long-Term Functional and Structural Consequences of Primary Blast Overpressure to the Eye
Allen, R. S., Motz, C. T., Feola, A., Chesler, K. C., Haider, R., Rao, S. R., Skelton, L. A., Fliesler, S. J., & Pardue, M. T. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5394 · Cited by 40 · see citing works
Self-citationInvolvement of tau phosphorylation in traumatic brain injury patients
Yang, W.-J., Chen, W., Chen, L., Guo, Y.-J., Zeng, J.-S., Li, G.-Y., & Tong, W.-S. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12644 · Cited by 38 · see citing works
Different forms of traumatic brain injuries cause different tactile hypersensitivity profiles
Wattiez, A., Castonguay, W. C., Gaul, O. J., Waite, J. S., Schmidt, C. M., Reis, A. S., Rea, B. J., Sowers, L. P., Cintrón-Pérez, C. J., Vázquez‐Rosa, E., et al. (2020) · Pain · doi:10.1097/j.pain.0000000000002103 · Cited by 33 · see citing works
Self-citationLübke, U., Six, J., Villanova, M., Boons, J., Vandermeeren, M., Ceuterick, C., Cras, P. P., & Martin, J. (1994) · PubMed Central · Cited by 30 · see citing works
Newman, A., Hayes, S. H., Rao, A., Allman, B., Manohar, S., Ding, D., Stolzberg, D. J., Lobarinas, E., Mollendorf, J., & Salvi, R. (2015) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2015.01.009 · Cited by 27 · see citing works
Geisen, U., Benk, C., Beyersdorf, F., Klemm, R., Trummer, G., Özbek, B., Kern, F., & Heilmann, C. (2015) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu513 · Cited by 25 · see citing works
Benefits of Enhancing Nicotinamide Adenine Dinucleotide Levels in Damaged or Diseased Nerve CellsPreprint
Pieper, A. A., & McKnight, S. L. (2018) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2018.83.037622 · Cited by 21 · see citing works
Self-citationTau progression in single severe frontal traumatic brain injury in human brains.
Okamura, Y., Kawakami, I., Watanabe, K., Oshima, K., Niizato, K., Ikeda, K., Akiyama, H., & Hasegawa, M. (2019) · Journal of Neurological Sciences · doi:10.1016/j.jns.2019.116495 · Cited by 17 · see citing works
Characterization of the Jet-Flow Overpressure Model of Traumatic Brain Injury in Mice
Shin, M., Vázquez‐Rosa, E., Cintrón-Pérez, C. J., Riegel, W. A., Harper, M. M., Ritzel, D. V., & Pieper, A. A. (2021) · Neurotrauma Reports · doi:10.1089/neur.2020.0020 · Cited by 12 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Modulation of cellular processes by histone and non-histone protein acetylation
Shvedunova, M., & Akhtar, A. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00441-y · Cited by 975 · see citing works
Neuroinflammation in Alzheimer disease
Heneka, M. T., van der Flier, W. M., Jessen, F., Hoozemanns, J., Thal, D. R., Boche, D., Brosseron, F., Teunissen, C., Zetterberg, H., Jacobs, A. H., et al. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01104-7 · Cited by 638 · see citing works
Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
Chen, Y., & Yu, Y. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02853-3 · Cited by 516 · see citing works
Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442 · see citing works
Tau-targeting therapies for Alzheimer disease: Current status and future directions
Congdon, E. E., Ji, C., Tetlow, A. M., Jiang, Y., & Sigurdsson, E. M. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00883-2 · Cited by 371 · see citing works
Cellular and pathological functions of tau
Bravo, C. P., Naguib, S. A., & Gan, L. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00753-9 · Cited by 245 · see citing works
Self-citationX-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women
Yan, Y., Wang, X., Chaput, D., Shin, M.-K., Koh, Y., Gan, L., Pieper, A. A., Woo, J.-A. A., & Kang, D. E. (2022) · Cell · doi:10.1016/j.cell.2022.09.002 · Cited by 144 · see citing works
Self-citationNeurodegenerative Disease Tauopathies
Creekmore, B. C., Watanabe, R., & Lee, E. B. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051222-120750 · Cited by 143 · see citing works
Wang, Z.-J., Li, X.-R., Chai, S.-F., Li, W.-R., Li, S., Hou, M., Li, J.-L., Ye, Y.-C., Cai, H.-Y., Hölscher, C., et al. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109716 · Cited by 125 · see citing works
Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification
Cummings, J. L., Osse, A. M. L., & Kinney, J. W. (2023) · Drugs · doi:10.1007/s40265-023-01938-w · Cited by 123 · see citing works
Luo, W., Yang, Z., Zheng, J., Cai, Z., Li, X., Liu, J., Guo, X., Luo, M., Fan, X., Cheng, M., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c09097 · Cited by 106 · see citing works
Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies
Zhang, X., Wang, J., Zhang, Z., & Ye, K. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00429-6 · Cited by 106 · see citing works
Zhang, X., Huang, X., Hang, D., Jin, J., Li, S., Zhu, Y., & Liu, H. (2024) · Science Advances · doi:10.1126/sciadv.adj4260 · Cited by 95 · see citing works
Protein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration
Nakamura, T., Oh, C.-K., Zhang, X., & Lipton, S. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.002 · Cited by 82 · see citing works
The Role of Post-Translational Modifications on the Structure and Function of Tau Protein
Ye, H., Han, Y., Li, P., Su, Z., & Huang, Y. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02002-0 · Cited by 74 · see citing works
Li, Y., Liu, Y., Yu, X., Xu, Y., Pan, X., Sun, Y. E., Wang, Y., Song, Y.-H., & Shen, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02013-w · Cited by 69 · see citing works
Wu, X., Liu, H., Wang, J., Zhang, S., Hu, Q., Wang, T., Cui, W., Shi, Y., Bai, H., Zhou, J., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01329-y · Cited by 68 · see citing works
Self-citationTargeting tau in Alzheimer's disease: from mechanisms to clinical therapy
Ye, J., Wan, H., Chen, S., & Liu, G. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385847 · Cited by 69 · see citing works
Cheng, F., Wang, F., Tang, J., Zhou, Y., Fu, Z., Zhang, P., Haines, J. L., Leverenz, J. B., Gan, L., Hu, J., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101379 · Cited by 63 · see citing works
Self-citationYang, J., Zhi, W., & Wang, L. (2024) · Molecules · doi:10.3390/molecules29122812 · Cited by 63 · see citing works
“The decrease in the acetylated form of tau is neuroprotective [76].”
BackgroundTau-targeting therapy in Alzheimer’s disease: Critical advances and future opportunities
Guo, Y., Li, S., Zeng, L.-H., & Tan, J. (2022) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2022.16 · Cited by 61 · see citing works
Drug repurposing for Alzheimer’s disease and other neurodegenerative disorders
Cummings, J. L., Zhou, Y., Stone, A. V., Cammann, D., Tonegawa‐Kuji, R., Cacho, J. R. F., & Cheng, F. (2025) · Nature Communications · doi:10.1038/s41467-025-56690-4 · Cited by 61 · see citing works
Self-citationGuen, Y. L., Luo, G., Ambati, A., Damotte, V., Jansen, I. E., Yu, E., Nicolas, A., de Rojas, I., Leal, T. P., Miyashita, A., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2302720120 · Cited by 56 · see citing works
Liu, Q., Wang, X., Hu, Y., Zhao, J.-N., Huang, C.-H., Li, T., Zhang, B.-G., He, Y., Wu, Y.-Q., Zhang, Z.-J., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102697 · Cited by 58 · see citing works
Hsp multichaperone complex buffers pathologically modified Tau
Moll, A., Ramirez, L. M., Ninov, M., Schwarz, J., Urlaub, H., & Zweckstetter, M. (2022) · Nature Communications · doi:10.1038/s41467-022-31396-z · Cited by 56 · see citing works
The Role and Pathogenesis of Tau Protein in Alzheimer’s Disease
Hong, X.-Y., Huang, L., Lei, F., Li, T., Luo, Y., Zeng, M., & Wang, Z. (2025) · Biomolecules · doi:10.3390/biom15060824 · Cited by 52 · see citing works
Ahluwalia, M., Kumar, M., Ahluwalia, P. K., Rahimi, S. Y., Vender, J. R., Raju, R. P., Hess, D. C., Baban, B., Vale, F. Ĺ., Dhandapani, K. M., et al. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105192 · Cited by 54 · see citing works
Increased Risk of Aging-Related Neurodegenerative Disease after Traumatic Brain Injury
Barker, S., Paul, B. D., & Pieper, A. A. (2023) · Biomedicines · doi:10.3390/biomedicines11041154 · Cited by 54 · see citing works
Self-citationRedox signaling and metabolism in Alzheimer's disease
Holubiec, M. I., Gellert, M., & Hanschmann, E.-M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1003721 · Cited by 52 · see citing works
Chen, Z., Wang, X., Du, S., Liu, Q., Xu, Z., Guo, Y., & Lin, X. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00900-6 · Cited by 51 · see citing works
TDP-43 drives synaptic and cognitive deterioration following traumatic brain injury
Gao, F., Hu, M., Zhang, J., Hashem, J., & Chen, C. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02449-w · Cited by 48 · see citing works
Ye, H., Wu, J., Liang, Z., Zhang, Y., & Huang, Z. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02194 · Cited by 46 · see citing works
Acetylation discriminates disease-specific tau deposition
Chakraborty, P., Rivière, G., Hebestreit, A., de Opakua, A. I., Vorberg, I. M., Andreas, L. B., & Zweckstetter, M. (2023) · Nature Communications · doi:10.1038/s41467-023-41672-1 · Cited by 47 · see citing works
Bai, H., Wu, Y., Li, H., Zhu, Y., Che, R., Wang, F., & Zhang, C. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.169511 · Cited by 48 · see citing works
Chen, Y., Galea, I., Macdonald, R. L., Wong, G. K. C., & Zhang, J. H. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104223 · Cited by 45 · see citing works
Langerscheidt, F., Wied, T., Kabbani, M. A. A., van Eimeren, T., Wunderlich, G., & Zempel, H. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12314-3 · Cited by 45 · see citing works
Sridharan, P. S., Koh, Y., Miller, E., Hu, D., Chakraborty, S., Tripathi, S. J., Kee, T. R., Chaubey, K., Vázquez‐Rosa, E., Barker, S., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101715 · Cited by 44 · see citing works
Self-citationQiu, Y., Hou, Y., Gohel, D., Zhou, Y., Xu, J., Bykova, M., Yang, Y., Leverenz, J. B., Pieper, A. A., Nussinov, R., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114128 · Cited by 40 · see citing works
Self-citationDisrupting pathologic phase transitions in neurodegeneration
Hurtle, B. T., Xie, L., & Donnelly, C. J. (2023) · Journal of Clinical Investigation · doi:10.1172/jci168549 · Cited by 39 · see citing works
The effects of nitric oxide in Alzheimer’s disease
Wang, L., Lu, D., Wang, X., Wang, Z., Li, W., & Chen, G. (2023) · Medical Gas Research · doi:10.4103/2045-9912.385939 · Cited by 37 · see citing works
Sun, B., Li, L., Harris, O. A., & Luo, J. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00478-5 · Cited by 43 · see citing works
Self-citationDonison, N. S., Palik, J., Volkening, K., & Strong, M. J. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00842-z · Cited by 39 · see citing works
White matter hyperintensities in former American football players
Alosco, M. L., Tripodis, Y., Baucom, Z., Adler, C. H., Balcer, L. J., Bernick, C. B., Mariani, M. L., Au, R., Banks, S. J., Barr, W., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12779 · Cited by 35 · see citing works
Acetylation in pathogenesis: Revealing emerging mechanisms and therapeutic prospects
Jiang, N., Li, W., Jiang, S., Xie, M., & Liu, R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115519 · Cited by 38 · see citing works
Xia, Y., Bell, B. M., & Giasson, B. I. (2021) · Scientific Reports · doi:10.1038/s41598-021-96627-7 · Cited by 33 · see citing works
The Beneficial Role of Sirtuin 1 in Preventive or Therapeutic Options of Neurodegenerative Diseases
Liu, H., Xu, S., Wang, C., Deng, Y. L., Xu, B., Yang, T., Sun, J., & Liu, W. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.09.021 · Cited by 30 · see citing works
Self-citationLiu, X., Wu, C., Zhang, Y., Li, G., Chen, S., Chen, Z., Liu, P., Wu, K., Wu, X., Zhou, T., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.152401 · Cited by 30 · see citing works
Liu, Y., Zhu, K., Peng, W., Liu, Z., & Mao, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02631-6 · Cited by 35 · see citing works
Sen, M. K., Almuslehi, M. S. M., Shortland, P. J., Mahns, D. A., & Coorssen, J. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147377 · Cited by 31 · see citing works
Interaction between resveratrol and SIRT1: role in neurodegenerative diseases
Zhu, L., Yang, M., Fan, L., Yan, Q., Zhang, L., Mu, P., & Lu, F. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03319-w · Cited by 31 · see citing works
Yu, D., Zhao, X.-Y., Meng, Q.-P., Teng, D., Deng, K., & Lin, N. (2022) · Brain Research · doi:10.1016/j.brainres.2022.148109 · Cited by 29 · see citing works
Brain injury biomarkers and applications in neurological diseases
Zhang, H., Wang, J., Qu, Y., Yang, Y., & Guo, Z. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003061 · Cited by 29 · see citing works
Xu, Q., Su, Z., Hu, Z. J., Yang, W., Xian, Y., & Lin, Z. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154441 · Cited by 29 · see citing works
Jain, S. K., Stevens, C. M., Margret, J. J., & Levine, S. N. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0245 · Cited by 27 · see citing works
Traumatic Brain Injury and Secondary Neurodegenerative Disease
Dodd, W., Panther, E. J., Pierre, K., Hernandez, J., Patel, D., & Lucke-Wold, B. P. (2022) · Trauma Care · doi:10.3390/traumacare2040042 · Cited by 27 · see citing works
Wu, W., Yuan, S., Tang, Y., Meng, X., Peng, M., Hu, Z., & Liu, W. (2023) · Nutrients · doi:10.3390/nu15132851 · Cited by 26 · see citing works
Sweeney, N., Kim, T. Y., Morrison, C. T., Li, L., Acosta, D. M., Liang, J., Datla, N. V., Fitzgerald, J. A., Huang, H., Liu, X., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02810-1 · Cited by 27 · see citing works
Self-citationAnti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
Bravo, C., Krukowski, K., Barker, S., Wang, C., Li, Y., Fan, L., Vázquez‐Rosa, E., Shin, M., Wong, M. Y., McCullough, L. D., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00733-9 · Cited by 25 · see citing works
Self-citationDisease-associated patterns of acetylation stabilize tau fibril formation
Li, L., Nguyen, B. A., Mullapudi, V., Li, Y., Saelices, L., & Joachimiak, L. A. (2023) · Structure · doi:10.1016/j.str.2023.05.020 · Cited by 25 · see citing works
Self-citationMitochondrial transport in neurons and evidence for its involvement in acute neurological disorders
Lu, D., Feng, Y., Liu, G., Yang, Y., Ren, Y., Chen, Z., Sun, X., Guan, Y.-X., & Wang, Z. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1268883 · Cited by 25 · see citing works
Wang, Y., Guo, Q., Wang, W., Wang, Y., Fang, K., Wan, Q., Li, H., & Wu, T. S. (2022) · Nanoscale · doi:10.1039/d2nr06081g · Cited by 24 · see citing works
Astrocytic NLRP3 cKO mitigates depression-like behaviors induced by mild TBI in mice.
Miao, H., Wang, J., Shao, J.-J., Song, R., Li, W., Sun, J.-K., Jia, S.-Y., Zhang, D., Li, X., Zhao, J., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106785 · Cited by 23 · see citing works
Lin, Z., Zhao, S., Li, X., Miao, Z., Cao, J., Chen, Y., Shi, Z., Zhang, J., Wang, D., Chen, S., et al. (2023) · Cell Research · doi:10.1038/s41422-023-00812-4 · Cited by 23 · see citing works
Yue, C., Luan, W.-W., Gu, H., Qiu, D., Ding, X., Liu, P., Wang, X., Hashimoto, K., & Yang, J. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.09.003 · Cited by 22 · see citing works
Buccilli, B., Alan, A., Baha’, A., Shahzad, A., Almealawy, Y. F., Chisvo, N., Ennabe, M., & Weinand, M. E. (2024) · Surgical neurology international · doi:10.25259/sni_773_2023 · Cited by 18 · see citing works
Neuroprotective Roles of the Biliverdin Reductase-A/Bilirubin Axis in the Brain
Paul, B. D., & Pieper, A. A. (2024) · Biomolecules · doi:10.3390/biom14020155 · Cited by 21 · see citing works
Self-citationDibenzo[b,f]oxepine Molecules Used in Biological Systems and Medicine
Krawczyk, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512066 · Cited by 20 · see citing works
Application of P7C3 Compounds to Investigating and Treating Acute and Chronic Traumatic Brain Injury
Sridharan, P. S., Miller, E., & Pieper, A. A. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01427-8 · Cited by 20 · see citing works
Self-citationJin, J., Zhang, H., Lu, Q., Tian, L., Yao, S., Lai, F., Liang, Y., Liu, C., Lu, Y., Tian, S., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00303 · Cited by 20 · see citing works
Perioperative neurocognitive disorders: Advances in molecular mechanisms and bioactive molecules
Mao, L., Wang, L., Huang, Z., Switzer, J. A., Hess, D. C., & Zhang, Q. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102885 · Cited by 21 · see citing works
Zou, Y. F., & Guan, L. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.801577 · Cited by 19 · see citing works
Alqahtani, S. M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Shokr, M. M., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-02000-9 · Cited by 21 · see citing works
Chaubey, K., Vázquez‐Rosa, E., Tripathi, S. J., Shin, M., Yu, Y., Dhar, M., Chakraborty, S., Yamakawa, M., Wang, X., Sridharan, P. S., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102535 · Cited by 18 · see citing works
Self-citationMartin, W., Sheynkman, G., Lightstone, F. C., Nussinov, R., & Cheng, F. (2021) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2021.09.001 · Cited by 18 · see citing works
Self-citationStructural basis for binding diversity of acetyltransferase p300 to the nucleosome
Hatazawa, S., Liu, J., Takizawa, Y., Zandian, M., Negishi, L., Kutateladze, T. G., & Kurumizaka, H. (2022) · iScience · doi:10.1016/j.isci.2022.104563 · Cited by 17 · see citing works
The regulatory role of Pin1 in neuronal death
Xiong, K., Wang, S., & Hu, X. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.341043 · Cited by 18 · see citing works
Koh, Y., Vázquez‐Rosa, E., Gao, F., Li, H., Chakraborty, S., Tripathi, S. J., Barker, S., Bud, Z., Bangalore, A., Kandjoze, U. P., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2417224122 · Cited by 17 · see citing works
Self-citationReduced ULK1 links impaired autophagy and mitophagy to Alzheimer’s disease pathology
Pan, J., Wang, P.-J., Zhang, J., Knapskog, A., Watne, L. O., Wang, H.-L., Lagartos-Donate, M. J., Lautrup, S., Mao, L.-P., Wang, Q., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01108-z · Cited by 19 · see citing works
Self-citationRahman, M. T., Bailey, E. M., Gansemer, B. M., Pieper, A. A., Manak, J. R., & Green, S. H. (2023) · Neurotherapeutics · doi:10.1007/s13311-022-01336-2 · Cited by 17 · see citing works
Self-citationPuangmalai, N., Bhatt, N. N., Bittar, A., Jerez, C., Shchankin, N., & Kayed, R. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102562 · Cited by 17 · see citing works
Zhao, T., Zhou, Y., Zhang, D., Han, D., Ma, J., Li, S., Li, T., Hu, S., & Li, Z. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148907 · Cited by 18 · see citing works
Putra, M. R. E., Rao, N. S., Gardner, C., Liu, G., Trommater, J., Bunney, M., Gage, M., Bassuk, A. G., Hefti, M. M., Lee, G. S., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae327 · Cited by 17 · see citing works
Xu, J., Song, W., Xu, Z., Danziger, M. M., Karavani, E., Zang, C., Chen, X., Li, Y., Paz, I. R., Gohel, D., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14373 · Cited by 17 · see citing works
Self-citationDing, Y., Chi, H., Shao, J., Shi, T., Yu, H. T., Wang, X., & Wang, X. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.676 · Cited by 17 · see citing works
Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer’s Disease
Lilek, J. N., Ajroud, K., Feldman, A. Z., Krishnamachari, S., Ghourchian, S., Gefen, T. D., Spencer, C., Kawles, A., Mao, Q., Tranovich, J. F., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220848 · Cited by 16 · see citing works
Self-citationHerbacetin alleviates ferroptosis via Hif-1α/SLC7A11/GPX4 axis in traumatic brain injury
Qian, W., Chen, X., Gu, L., Lin, X., Chen, J., Xu, D., Wang, H., Long, F., Zhuge, Q., Zhang, P., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.06.030 · Cited by 15 · see citing works
Self-citationSanturro, A., Simone, M. D., Choucha, A., Morena, D., Consalvo, F., Romano, D. G., Terrasi, P., Corrivetti, F., Scrofani, R., Narciso, N., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167808 · Cited by 15 · see citing works
Cytokines and related signaling pathways in traumatic brain injury
Zhu, L., Huang, S., Chen, W., Li, K., & Sheng, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1738589 · Cited by 15 · see citing works
Modifiable risk factors of dementia linked to excitation-inhibition imbalance
Hafizi, S., & Rajji, T. K. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101804 · Cited by 15 · see citing works
Ding, X., Cao, S., Wang, Q., Du, B., Lu, K., Qi, S., Cheng, Y., Tuo, Q., Liang, W., & Lei, P. (2024) · Advanced Science · doi:10.1002/advs.202306399 · Cited by 14 · see citing works
Ferroptosis: A new strategy for targeting Alzheimer’s disease
Qiang, R. R., Xiang, Y., Zhang, L., Bai, X. Y., Zhang, D., Li, Y. J., Yang, Y. L., & Liu, X. L. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105773 · Cited by 15 · see citing works
The importance of behavioral interventions in traumatic brain injury
Buccilli, B., Alan, A., Aljeradat, B., Shahzad, A., Almealawy, Y. F., Chisvo, N. S., Ennabe, M., & Weinand, M. E. (2024) · Surgical Neurology International · doi:10.25259/sni_776_2023 · Cited by 14 · see citing works
Li, Y., Wang, Y., He, Y., Ye, T.-T., Huang, X., Wu, H., Ma, T.-X., Pritchard, H. W., Wang, X., & Xue, H. (2024) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiae197 · Cited by 14 · see citing works
Liang, F., Wang, M., Li, J., & Guo, J. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03568-y · Cited by 14 · see citing works
Insulin-incubated palladium clusters promote recovery after brain injury
Fu, S., Zhao, S. Y., Chen, H., Yang, W., Xia, X., Xu, X., Liang, Z., Feng, X., Wang, Z., Ai, P., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01495-6 · Cited by 14 · see citing works
Treatment and Rehabilitation for Traumatic Brain Injury: Current Update
Min, J. H., & Shin, Y. (2022) · Brain & Neurorehabilitation · doi:10.12786/bn.2022.15.e14 · Cited by 16 · see citing works
Pluta, R. M., & Czuczwar, S. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063091 · Cited by 13 · see citing works
Yip, P. K., Hasan, S., Liu, Z., & Uff, C. E. G. (2022) · Biomedicines · doi:10.3390/biomedicines10030518 · Cited by 13 · see citing works
Unknown roles of tau pathology in neurological disorders. Challenges and new perspectives
Olesen, M. A., Villavicencio-Tejo, F., Cuevas-Espinoza, V., & Quintanilla, R. A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102594 · Cited by 12 · see citing works
Ma, W., Zhao, G., Liu, R., Li, K., Wu, W., Liu, J., He, X., Hou, L., Yu, P., & Mao, L. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202502163 · Cited by 12 · see citing works
- Authors
- Shin, M.-K., Vázquez-Rosa, E., Koh, Y., Dhar, M., Chaubey, K., Cintrón-Pérez, C. J., Barker, S., Miller, E., Franke, K., Noterman, M. F., Seth, D., Allen, R. S., Motz, C. T., Rao, S. R., Skelton, L. A., Pardue, M. T., Fliesler, S. J., Wang, C., Tracy, T. E., Gan, L., Liebl, D. J., Savarraj, J. P. J., Torres, G. L., Ahnstedt, H., McCullough, L. D., Kitagawa, R. S., Choi, H. A., Zhang, P., Hou, Y., Chiang, C.-W., Li, L., Ortiz, F., Kilgore, J. A., Williams, N. S., Whitehair, V. C., Gefen, T., Flanagan, M. E., Stamler, J. S., Jain, M. K., Kraus, A., Cheng, F., Reynolds, J. D., & Pieper, A. A.
- Affiliations
- University Hospitals of Cleveland (US)
- University of Iowa (US)
- Georgia Institute of Technology (US)
- Buffalo VA Medical Center (US)
- Gladstone Institutes (US)
- Buck Institute for Research on Aging (US)
- Weill Cornell Medicine (US)
- University of Miami (US)
- The University of Texas Health Science Center at Houston (US)
- The Ohio State University (US)
- Cleveland Clinic (US)
- The University of Texas Southwestern Medical Center (US)
- MetroHealth (US)
- Northwestern University (US)
- Case Western Reserve University (US)
- Cornell University (US)
- Corresponding author
- Pieper, Andrew A.
- ORCID
- Shin, Min-Kyoo
- Koh, Yeojung
- Dhar, Matasha
- Chaubey, Kalyani
- Cintrón-Pérez, Coral J.
- Barker, Sarah
- Miller, Emiko
- Franke, Kathryn
- Noterman, Maria F.
- Seth, Divya
- Allen, Rachael S.
- Motz, Cara T.
- Rao, Sriganesh Ramachandra
- Skelton, Lara A.
- Pardue, Machelle T.
- Fliesler, Steven J.
- Wang, Chao
- Tracy, Tara E.
- Gan, Li
- Liebl, Daniel J.
- Savarraj, Jude P.J.
- Ahnstedt, Hilda
- McCullough, Louise D.
- Choi, H. Alex
- Zhang, Pengyue
- Chiang, Chien-Wei
- Li, Lang
- Kilgore, Jessica A.
- Williams, Noelle S.
- Whitehair, Victoria C.
- Gefen, Tamar
- Flanagan, Margaret E.
- Stamler, Jonathan S.
- Jain, Mukesh K.
- Kraus, Allison
- Cheng, Feixiong
- Reynolds, James D.
- Pieper, Andrew A.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 184
- Issue
- 10
- Pages
- 2715-2732.e23
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC8491234
- OpenAlex
- W3152963650
- Cited by
- 226
- References
- 64
- Citations by year
- 2026: 36 · 2025: 60 · 2024: 45 · 2023: 40 · 2022: 34 · 2021: 11
- FWCI
- 20.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX002439, IK2 RX002928)
- National Institutes of Health (5p30ag062428-02, UL1TR001412)
- National Institute on Aging (P30-AG062428, F32AG043301, R01AG066707, K01AG057862, R01AG062566, P30AG013854, K08AG065463)
- National Cancer Institute (P01CA217797, T32CA078586)
- National Institute of General Medical Sciences (T32GM007250)
- National Institute of Neurological Disorders and Stroke (R01NS098740)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Epidemiology › Traumatic Brain Injury Research
- Health Sciences › Medicine › Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- tau acetylation, traumatic brain injury, Alzheimer's disease, SIRT1, neurodegeneration, neurobehavioral impairment, blood biomarkers, salsalate, diflunisal, neuroprotection
- MeSH terms
- Neuroprotection, Brain Injuries, Traumatic, p300-CBP-Associated Factor, Acetylation, Alzheimer Disease, Animals, Anti-Inflammatory Agents, Non-Steroidal, Cell Line, Diflunisal, Female, Humans, Male, Mice, Inbred C57BL, Neurons, Salicylates, Biomarkers, tau Proteins, Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating), p300-CBP Transcription Factors, Mice, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
